Can Cannabis Replace Opioids for Chronic Pain? What We Know and What Remains Uncertain
This 2025 narrative review explores cannabinoid analgesia mechanisms and their role in chronic pain management. It highlights biological plausibility and clinical evidence supporting cannabinoids for neuropathic and arthritis pain. However, significant…
Mapping the Landscape: What We Know (and Don’t Know) About Reducing Cannabis Harms
This cannabis harm reduction strategies review maps existing interventions without assessing their effectiveness. It highlights the fragmented evidence base and the need for rigorous trials. Clinicians should focus on biologically plausible risk…
CBD’s Promise Outpaces Its Proof: A Comprehensive Review Finds Most Cannabis Products Lack Regulatory-Grade Evidence
CBD therapeutic development is advancing but regulatory-grade evidence remains limited. Most cannabis products lack robust clinical support beyond rare epilepsy syndromes. This review highlights the urgent need for rigorous trials and quality standards.
Cannabis Stocks To Research – March 26th | MarketBeat
This article covers cannabis stocks research March 26th MarketBeat with a focus on clinical evidence and patient safety. It highlights the distinction between financial market trends and medical cannabis treatment. Clinicians should rely on clinical data…
Unraveling Lennox-Gastaut Syndrome: Molecular Pathogenesis and Therapeutic Strategies
Lennox-Gastaut syndrome treatment challenges arise from its complex network dysfunction and drug-resistant seizures. Precision medicine approaches targeting molecular pathways offer new hope. CBD has shown efficacy as adjunctive therapy for this severe…
Evaluating Clinical Evidence of Cannabis for Anxiety, Depression, and PTSD
This article discusses clinical evidence cannabis anxiety depression ptsd with a focus on research quality and patient safety. Emerging findings highlight the need for peer-reviewed data in mental health. Clinicians should carefully evaluate cannabis…
Therapeutic Potential and Pharmacological Mechanisms of Cannabinoids in Alleviating Chemotherapy-Induced Organ Toxicity
Cannabinoids chemotherapy organ protection research highlights their potential to reduce organ toxicities caused by chemotherapy. These include cardiotoxicity, nephrotoxicity, hepatotoxicity, and neurotoxicity. Understanding pharmacological mechanisms is…
Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies.
This review addresses cannabinoid therapies rare diseases by examining clinical evidence for less-common disorders. It highlights formulation strategies tailored to individual patient needs. The article provides a framework for clinicians considering…
Medical Cannabis and Epilepsy: Reviewing the Evidence
Cannabis epilepsy treatment evidence highlights the anticonvulsant properties of CBD and THC in managing seizures. Approximately 30% of epilepsy patients have drug-resistant forms that may benefit from cannabis-based therapies. Understanding this…
Therapeutic Cannabis Use: Biological and Emotional Health Insights
Therapeutic cannabis use clinical evidence spans biological health and emotional balance domains. This includes research on sleep, pain relief, stress, and anxiety management. Understanding this evidence helps clarify cannabis's role in health.